Delivery Order SPE2DB22D3301-SPE2DB24FZ2RU

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $5,292.46 firm-fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, to supply 4,565,406,862 tablets of Citalopram HBR 40 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $27,074.76 contract is for the delivery of 4,564,041 units of the generic antidepressant medication Citalopram HBR 20 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued up to $999,999,999.00...
This federal contract award, valued at $1,166.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,873,359 tablets of the medication Citalopram HBR 40 mg, with a completion date of April 11, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,311,022 units of Citalopram HBR 40 MG Tablets in 500-count packages. The contract has a ceiling value of $7,265.69 and a completion date of January 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company,...
This is a $14,682.23 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,122 tablets of 40mg Citalopram HBR, a generic antidepressant medication, to support federal healthcare programs. The contract has a period of performance through July 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,399,608 units of Citalopram HBR 40 mg tablets, a medication used to treat mental health conditions. The contract has a firm fixed price of $7,551.71 and a period of performance through January 23, 2024. The contract was not set aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,767.48 firm fixed-price delivery order is for the supply of 4,562,399,678 tablets of Citalopram HBR 40 mg, a generic medication used to treat depression. The contract has an ultimate completion date of October 6, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract is for the supply of 4,565,709,980 tablets of Citalopram Hydrobromide 40 mg, a prescription antidepressant medication. The contract has a ceiling value of $4,057.80 and runs through September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,039,767 units of Citalopram HBR 40 mg tablets. The $13,774.05 firm fixed-price contract has a completion date of January 27, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, that serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is for the delivery of 4,560,392 units of Citalopram HBr 40 mg tablets, a generic antidepressant medication, to the Defense Logistics Agency (DLA). The $3,433.00 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 27, 2023, with a performance period through March 28, 2023. This appears to be a discrete delivery order placed against an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2RU
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $4,357.57 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for 4,565,423,516 tablets of 40mg Citalopram HBR, an antidepressant medication. The contract has a firm fixed price and an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, that enables the agency to efficiently procure a wide range of pharmaceutical and medical supplies to support military treatment facilities and programs worldwide. The contract does not have a set-aside designation.

Generated 11/11/24, 9:25 AM